CJ
PRCT icon

Caitlin John’s Procept Biorobotics PRCT Stock Holding History

Caitlin John’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339 Hold
15
– – ﹤0.01% 961
2026
Q1 		$375 Hold
15
– – ﹤0.01% 876
2025
Q4 		$472 Hold
15
– – ﹤0.01% 856
2025
Q3 		$535 Buy
+15
New +$685 ﹤0.01% 818

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caitlin John's PRCT Position: Q2 2026 in Review

Caitlin John held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 15 shares worth $339. The position accounts for ﹤0.01% of the portfolio, ranked #961.

Caitlin John first reported a position in PRCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $535 in Q3 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Caitlin John held 15 shares of Procept Biorobotics worth $339 as of Q2 2026.
  • Caitlin John left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #961 holding.
  • Caitlin John first reported a position in Procept Biorobotics in Q3 2025 and has held it in 4 quarters since.
  • Caitlin John's Procept Biorobotics position peaked at $535 in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.